A Comparative Study of Mefloquine and S-P as Prophylaxis Against Malaria in Pregnant HIV + Patients
A Comparative Study of Mefloquine and Sulphadoxine-pyrimethamine as Prophylaxis Against Malaria in Pregnant Human Immunodeficiency Virus Positive Patients
Sponsor: ORIYOMI OMOTOYOSI AKINYOTU
A PHASE1 clinical study on Malaria in Pregnant HIV + Patients, this trial is completed. The trial is conducted by ORIYOMI OMOTOYOSI AKINYOTU and has accumulated 8 data snapshots since 2015. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE1
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE1
-
Dec 2017 — Jun 2018 [monthly]
Completed PHASE1
Status: Unknown Status → Completed
▶ Show 3 earlier versions
-
Sep 2017 — Dec 2017 [monthly]
Unknown Status PHASE1
Status: Not Yet Recruiting → Unknown Status
-
Feb 2017 — Sep 2017 [monthly]
Not Yet Recruiting PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Not Yet Recruiting PHASE1
First recorded
Sep 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- ORIYOMI OMOTOYOSI AKINYOTU
- University of Ibadan
For direct contact, visit the study record on ClinicalTrials.gov .